New Age Alpha Advisors LLC Buys Shares of 44,804 Maximus, Inc. (NYSE:MMS)

New Age Alpha Advisors LLC bought a new position in shares of Maximus, Inc. (NYSE:MMS) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 44,804 shares of the health services provider’s stock, valued at approximately $3,345,000. New Age Alpha Advisors LLC owned 0.08% of Maximus as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently modified their holdings of the business. Nordea Investment Management AB bought a new position in Maximus in the fourth quarter worth about $4,618,000. Fort Washington Investment Advisors Inc. OH raised its position in shares of Maximus by 39.1% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider’s stock worth $22,132,000 after purchasing an additional 83,390 shares during the period. IFP Advisors Inc lifted its holdings in shares of Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock worth $59,000 after purchasing an additional 302 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new position in Maximus during the 4th quarter valued at approximately $1,113,000. Finally, Legato Capital Management LLC grew its stake in Maximus by 33.9% during the 4th quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider’s stock worth $2,399,000 after buying an additional 8,138 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.

Maximus Stock Performance

Shares of NYSE MMS opened at $68.18 on Friday. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.97. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. The company has a market cap of $3.86 billion, a PE ratio of 14.66 and a beta of 0.71. The stock has a 50 day simple moving average of $70.00 and a 200-day simple moving average of $77.83.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, equities research analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were given a dividend of $0.30 per share. The ex-dividend date was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.76%. Maximus’s dividend payout ratio (DPR) is 25.81%.

Insiders Place Their Bets

In other news, Director Jan Madsen sold 2,439 shares of the business’s stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now owns 18,097 shares of the company’s stock, valued at approximately $1,225,347.87. The trade was a 11.88 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of the firm’s stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the transaction, the insider now directly owns 2,512 shares of the company’s stock, valued at $171,167.68. This represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Analysts Set New Price Targets

Several brokerages have recently issued reports on MMS. StockNews.com downgraded shares of Maximus from a “buy” rating to a “hold” rating in a report on Friday, February 14th. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective on the stock in a research report on Thursday, January 2nd.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.